Abstract:Objective. To observe the changes of serum adiponectin (AP) levels in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and explore the correlation between serum AP and polysomnography (PSG) parameters in patients with OSAHS. Methods. The data of subjects who underwent PSG at the hospital between January 2021 and December 2022 were collected retrospectively and divided into simple snoring group (AHI < 5 times/h, n = 45), mild OSAHS group (5 ≤ AHI 30 times/h, n = 60). The general data, PSG indices, and serological indices of the subjects were collected and compared between groups. Pearson correlation analysis and partial correlation analysis were employed to examine the correlation between serum AP level and PSG parameters. Ordered logistic regression was employed to analyze the risk factors influencing the severity of OSAHS. The predictive capability of the serum AP level in determining the occurrence of OSAHS was assessed using ROC. The serum AP levels of subjects with different subtypes of PSG indicators were compared. Results. In the simple snoring group, mild OSAHS group, moderate OSAHS group, and severe OSAHS group, there were statistically significant differences in microarousal count, MAI, AHI, times of blood oxygen decreased by ≥ 3%, L-SaO2, and TS90% among the 4 groups ( P < 0.05 ). The level of serum AP was positively correlated with L-SaO2 and negatively correlated with the proportion of REM, microarousal count, MAI, AHI, times of blood oxygen decreased by ≥ 3%, TS90%, and LP ( P < 0.05 ). High AHI was a risk factor affecting the severity of OSAHS (95% CI: 1.446–4.170). The AUC of serum AP level in diagnosing OSAHS was 0.906 (95% CI: 0.8601–0.9521), and when the Youden Index was 0.678, the sensitivity was 88.9%, and the specificity was 78.9% ( P < 0.0001 ). In the population with a high microarousal count, high AHI, and high times of blood oxygen decreased by ≥ 3% and high TS90%, the serum AP level was lower than that in the low-level population ( P < 0.05 ). In the population with high L-SaO2, the serum AP level was higher than that in low-level population ( P < 0.05 ). Conclusion. The level of serum AP decreased with the increase of the disease severity of patients with OSAHS and demonstrates a significant predictive capability for the occurrence of OSAHS. Monitoring the level of serum AP can effectively forecast the risk of OSAHS. Furthermore, alterations in serum AP levels are associated with both hypoxemia and a heightened frequency of arousal in patients with OSAHS.

Glomerular Filtration Rate and Proteinuria in Obstructive Sleep Apnea Syndrome Patients

Association between obstructive sleep apnea and 24-h urine protein quantification in patients with hypertension

The relationship between obstructive sleep apnea-hypopnea syndrome and blood uric acid levels

Serum Uric Acid Is Independently Associated with Risk of Obstructive Sleep Apnea-Hypopnea Syndrome in Chinese Patients with Type 2 Diabetes

Urine biomarkers of renal renin-angiotensin system activity: Exploratory analysis in humans with and without obstructive sleep apnea

Serum uric acid and arterial lactate levels in patients with obstructive sleep apnea syndrome: the effect of CPAP treatment

Changes of Serum Adiponectin Level in Patients with Obstructive Sleep Apnea Hypopnea Syndrome and Its Relationship with Sleep Monitoring Indexes

Analysis of the Clinicl Characteristics in 148 Patients with Snoring and Obstructive Sleep Apnea Hypopnea Syndrome

Associations between obstructive sleep apnea and sleep characteristics with chronic kidney disease in rural Pennsylvania

Correlation between serum uric acid and pulmonary arterial hypertension based on echo probability in patients with obstructive sleep apnea syndrome

Association between obstructive sleep apnea and 24-h urine chemistry risk factors for urinary stone disease

Evaluation of the Clinical Characteristics of Patients with Positional Obstructive Sleep Apnea Hypopnea Syndrome

Frequency of overactive bladder (OAB) and the factors affecting it in patients with obstructive sleep apnea syndrome (OSAS)

The effect of PAP on UACR and metabolic indexes in patients with MS and OSAHS

Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome

Ultrasonographic characteristics of intracranial and extracranial atherosclerosis lesion in patients with obstructive sleep apnea syndromes

Arterial Stiffness Changes and Plasma Renin-Angiotensin-Aldosterone in Patients with Hypertention and Obstructive Sleep Apnea-Hypopnea Syndrome

Increasing obstructive sleep apnea risk is associated with albuminuria in Korean adults: cross-sectional analysis

The relationship between obstructive sleep apnea and risk of renal impairment in patients with hypertension, a longitudinal study

0452 C-reactive Protein Is Associated with Hypertension in Mild-to-Moderate Obstructive Sleep Apnea: Age Effect

Association of adiponectin level and obstructive sleep apnea prevalence in obese subjects